Last reviewed · How we verify

NCT04335318: RELIANT

Real Life AI in Polyp Detection

Completed NA Last updated 8 April 2021
What this trial tests

NA trial testing AI-assisted colonoscopy in Colonic Polyp in 230 participants. Completed in 1 October 2020.

Timeline
1 May 2020
Primary endpoint
31 August 2020
1 October 2020

Quick facts

Lead sponsorWuerzburg University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment230
Start date1 May 2020
Primary completion31 August 2020
Estimated completion1 October 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Wuerzburg University Hospital

Who can join

18 and older, any sex, with Colonic Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to compare the polyp detection rate (PDR) of endoscopists unaware of a commercially available artificial intelligence (AI) device for polyp detection during colonoscopy and the PDR of endoscopists with the aid of such a device. Moreover, an extensive characterization of the performance of this device will be done.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. <b>UEG</b> Week 2020 Poster Presentations.
    · 2020 · cited 5× · PMID 33043826 · DOI 10.1177/2050640620927345
  2. UEG Week 2021 Poster Presentations
    · 2021

Verify or expand the search:

Other trials of AI-assisted colonoscopy

Trials testing the same drug.

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

Other Wuerzburg University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing